Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3 | 25496826 | intron variant | C/A;T | snv |
|
0.800 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
1.000 | 0.040 | 3 | 24931301 | intron variant | T/C | snv | 0.16 |
|
Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
3 | 25215505 | intron variant | G/A | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.120 | 3 | 25501230 | stop gained | C/G;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.120 | 3 | 25501230 | stop gained | C/G;T | snv |
|
0.700 | 0 | ||||||||||||
|
1.000 | 3 | 25596470 | frameshift variant | -/TC | delins |
|
0.700 | 0 | |||||||||||||
|
0.851 | 0.120 | 3 | 25596428 | missense variant | C/A;T | snv |
|
Nervous System Diseases | 0.700 | 1.000 | 5 | 2007 | 2016 | ||||||||
|
0.851 | 0.120 | 3 | 25596428 | missense variant | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 1.000 | 5 | 2007 | 2016 | ||||||||
|
0.851 | 0.120 | 3 | 25596428 | missense variant | C/A;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.700 | 1.000 | 5 | 2007 | 2016 | ||||||||
|
0.851 | 0.120 | 3 | 25596428 | missense variant | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms | 0.020 | 1.000 | 2 | 2013 | 2016 | ||||||||
|
0.851 | 0.120 | 3 | 25596428 | missense variant | C/A;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases | 0.020 | 1.000 | 2 | 2013 | 2016 | ||||||||
|
0.851 | 0.120 | 3 | 25596428 | missense variant | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.020 | 1.000 | 2 | 2013 | 2016 | ||||||||
|
0.851 | 0.120 | 3 | 25596428 | missense variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
0.851 | 0.120 | 3 | 25596428 | missense variant | C/A;T | snv |
|
0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.851 | 0.120 | 3 | 25596428 | missense variant | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
3 | 25075091 | intron variant | A/G | snv | 0.53 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
3 | 25075091 | intron variant | A/G | snv | 0.53 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
0.851 | 0.080 | 3 | 25439731 | intron variant | T/A | snv | 0.27 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.080 | 3 | 25439731 | intron variant | T/A | snv | 0.27 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.080 | 3 | 25439731 | intron variant | T/A | snv | 0.27 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.080 | 3 | 25439731 | intron variant | T/A | snv | 0.27 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.080 | 3 | 24922859 | intron variant | A/G | snv | 0.31 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.080 | 3 | 24922859 | intron variant | A/G | snv | 0.31 |
|
Female Urogenital Diseases and Pregnancy Complications | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
3 | 25064946 | intron variant | A/G | snv | 0.53 |
|
0.700 | 1.000 | 5 | 2015 | 2019 | ||||||||||
|
3 | 25064946 | intron variant | A/G | snv | 0.53 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2017 | 2017 |